---
title: "Azelnidipine - Hypertensive Disorder"
sidebar: mydoc_sidebar
permalink: db09230-mesh-d006973-1.html
toc: false 
---


Path ID: `DB09230_MESH_D006973_1`
{% include image.html url="images/db09230-mesh-d006973-1.png" file="db09230-mesh-d006973-1.png" alt="db09230-mesh-d006973-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C061679 | azelnidipine | Drug |
| UniProt:Q02641 | Voltage-dependent L-type calcium channel subunit beta-1 | Protein |
| GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel | BiologicalProcess |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| HP:0032263 | Increased blood pressure | PhenotypicFeature |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Azelnidipine | DECREASES ACTIVITY OF | Voltage-Dependent L-Type Calcium Channel Subunit Beta-1 |
| Voltage-Dependent L-Type Calcium Channel Subunit Beta-1 | POSITIVELY REGULATES | Calcium Ion Transmembrane Transport Via High Voltage-Gated Calcium Channel |
| Calcium Ion Transmembrane Transport Via High Voltage-Gated Calcium Channel | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Increased Blood Pressure |
| Increased Blood Pressure | MANIFESTATION OF | Hypertensive Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09230#mechanism-of-action](https://go.drugbank.com/drugs/DB09230#mechanism-of-action)
